🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🎙️ New episode of #DiabetesDialogue! We’re breaking down the full SURMOUNT-5 results: 📊 Tirzepatide led to greater weight loss than semaglutide 🎯 20.2% avg vs 13.7% avg weight loss Tune in: hcplive.com/view/diabetes-… Diana Isaacs, PharmD, BC-ADM, CDCES Natalie Bellini #obesity #clinicaltrials $LLY

Another great #SOCS podcast filming!🎙️ Great to hear things from a patient perspective when it comes to serious skin conditions like HS. Worth a watch: hcplive.com/view/skin-of-c… #HidradenitisSuppurativa #dermatology

Excited to preview an upcoming episode of #DontMissABeat where Ahmad Masri joins the program to discuss the latest in management of ATTR-CM. Check back on HCPLive later this week for the full episode!

Really enjoyed this conversation with experts on pathophysiology, diagnosis and new treatments for C3 glomerulopathy, discussing data on pegcetacoplan & iptacopan from recent phase 3 randomised trials, VALIANT and APPEAR-C3G

#BWH Clinical Trials Outcomes Center at #ESCHFA #HeartFailure2025 4 #LBCT presentations: 🔥 #FINEARTSHF Blinded Drug Withdrawal 🔥 #FINEARTSHF Readmissions 🔥 #FINEARTSHF Risk-Benefit Trade-off 🔥 #HFpEF Risk Score Comparison (H2FPEF, HFA-PEFF, HFpEF-ABA) See everyone soon 🇷🇸

⏰It's time! The 2025 ACOG Annual Clinical and Scientific Meeting has officially begun. Check back with Contemporary OB/GYN frequently for the latest meeting updates and exclusive expert interviews. #ACOG2025 hubs.li/Q03mYSDh0

ACOG has released a new Clinical Consensus statement on pain management in-office uterine and cervical procedures. #ACOG2025 Check out what this means for you and your practice here👉: hubs.ly/Q03mYZw_0

Have you seen the latest #SkinofColorSavvy podcast?🎙️ The show, hosted by Skin of Color and HCPLive, included in depth discussions of impacts of #HidradenitisSuppurativa on patients with diverse skin types. Check out the full episode here: hcplive.com/view/skin-of-c…

🎧 New on #PearlsAndPerspectives: Amy Pearlman, MD talks with men’s health expert @AlexTatem about testosterone therapy—what works, what doesn’t, and why it’s often misunderstood. From injectables to orals to estradiol, this episode has it all. 🔗 Listen: hubs.li/Q03n1KkY0

The HCPLive team has arrived in San Francisco!☀️ We're here covering #ATS2025, and there's a lot of new late-breaking data and interviews with investigators coming in the next few days here. Stay tuned... hcplive.com/conference/ats #pulmonology

Should urologists or providers administering #TRT be ordering lipid panels? Hear from Amy Pearlman, MD and Dr. Alex Tatem on their approach in the latest #PearlsAndPerspectives. Check it out on Urology Times: urologytimes.com/view/pearls-pe… #MensHealth #Testosterone

From #ATS2025: New data shed light on improvements in waitlist outcomes following the implementation of allocation guidelines for lung transplants that prioritize medical urgency. Learn more: hcplive.com/view/lung-tran…

We're here on site at #ATS2025 American Thoracic Society (ATS) and it is incredibly busy! The conference is fully underway and late-breaking data as well as session coverage will be posted on our site, so stay informed by viewing it here for the next few days: hcplive.com/conference/ats

New at #ATS2025: Dupilumab (DUPIXENT) significantly reduced #asthma exacerbations/improved control in children with moderate-to-severe type 2 asthma, new data suggest, regardless of duration. This was a post-hoc analysis led by Wanda Phipatanakul. 🔗View summary: hcplive.com/view/dupilumab…

New at #ATS2025: BATURA phase 3 data provide evidence supporting albuterol/budesonide (Airsupra)’s benefit as standard of care for as-needed rescue treatment in #asthma. Monica Kraft, MD, of Icahn School of Medicine at Mount Sinai, spoke with HCPLive on her team's findings: hcplive.com/view/as-needed…

Today is the last day of #ATS2025! New late-breaking data and interviews with experts on site have been a constant here at the meeting in San Francisco. And there's more to come today AND tomorrow! View the latest conference news here👇 🔗 hcplive.com/conference/ats

Had a great time speaking with HCPLive about our study on language-based disparities in CRC screening. We found that non-English primary language was linked to increased risk of early repeat colonoscopy, highlighting the need for more equitable, language-accessible care.

From #ATS2025: Pooled data from the phase 3 BOREAS and NOTUS trials shed light on dupilumab’s sustained impact on lung function parameters in patients with #COPD and type 2 inflammation. hcplive.com/view/dupilumab…